These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 25583540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
    Yanar F, Carugo D, Zhang X.
    Molecules; 2023 Jul 27; 28(15):. PubMed ID: 37570666
    [Abstract] [Full Text] [Related]

  • 3. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT, Kostarelos K.
    Nanomedicine (Lond); 2007 Feb 27; 2(1):85-98. PubMed ID: 17716195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR.
    Int J Nanomedicine; 2018 Feb 27; 13():4727-4745. PubMed ID: 30154657
    [Abstract] [Full Text] [Related]

  • 6. Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery.
    Li Z, Ye E, David, Lakshminarayanan R, Loh XJ.
    Small; 2016 Sep 27; 12(35):4782-4806. PubMed ID: 27482950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interlocked systems in nanomedicine.
    Ornelas-Megiatto C, Becher TB, Megiatto JD.
    Curr Top Med Chem; 2015 Sep 27; 15(13):1236-56. PubMed ID: 25858133
    [Abstract] [Full Text] [Related]

  • 9. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT, Kostarelos K.
    Acc Chem Res; 2011 Oct 18; 44(10):1094-104. PubMed ID: 21812415
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
    van Elk M, Murphy BP, Eufrásio-da-Silva T, O'Reilly DP, Vermonden T, Hennink WE, Duffy GP, Ruiz-Hernández E.
    Int J Pharm; 2016 Dec 30; 515(1-2):132-164. PubMed ID: 27725268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibody-targeted nanoparticles for cancer therapy.
    Fay F, Scott CJ.
    Immunotherapy; 2011 Mar 30; 3(3):381-94. PubMed ID: 21395380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI.
    ChemMedChem; 2015 Jan 30; 10(1):24-38. PubMed ID: 25319803
    [Abstract] [Full Text] [Related]

  • 16. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK, Chung BH, Chung SJ.
    Curr Drug Targets; 2018 Feb 19; 19(4):300-317. PubMed ID: 27262486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biodegradable polymeric nanoparticles based drug delivery systems.
    Kumari A, Yadav SK, Yadav SC.
    Colloids Surf B Biointerfaces; 2010 Jan 01; 75(1):1-18. PubMed ID: 19782542
    [Abstract] [Full Text] [Related]

  • 19. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ, Bai X, Lee SB.
    Drug Discov Today; 2007 Aug 01; 12(15-16):650-6. PubMed ID: 17706547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.